Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803 - PubMed (original) (raw)
. 2006 Aug 1;24(22):3535-41.
doi: 10.1200/JCO.2006.06.0863. Epub 2006 Jul 5.
Denise Heseltine, Donna Niedzwiecki, Donna Hollis, Leonard B Saltz, Robert J Mayer, James Thomas, Heidi Nelson, Renaud Whittom, Alexander Hantel, Richard L Schilsky, Charles S Fuchs
Affiliations
- PMID: 16822843
- DOI: 10.1200/JCO.2006.06.0863
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803
Jeffrey A Meyerhardt et al. J Clin Oncol. 2006.
Abstract
Purpose: Regular physical activity reduces the risk of developing colon cancer, however, its influence on patients with established disease is unknown.
Patients and methods: We conducted a prospective observational study of 832 patients with stage III colon cancer enrolled in a randomized adjuvant chemotherapy trial. Patients reported on various recreational physical activities approximately 6 months after completion of therapy and were observed for recurrence or death. To minimize bias by occult recurrence, we excluded patients who experienced recurrence or died within 90 days of their physical activity assessment.
Results: Compared with patients engaged in less than three metabolic equivalent task (MET) -hours per week of physical activity, the adjusted hazard ratio for disease-free survival was 0.51 (95% CI, 0.26 to 0.97) for 18 to 26.9 MET-hours per week and 0.55 (95% CI, 0.33 to 0.91) for 27 or more MET-hours per week. The adjusted P for trend was .01. Postdiagnosis activity was associated with similar improvements in recurrence-free survival (P for trend = .03) and overall survival (P for trend = .01). The benefit associated with physical activity was not significantly modified by sex, body mass index, number of positive lymph nodes, age, baseline performance status, or chemotherapy received. Moreover, the benefit remained unchanged even after excluding participants who developed cancer recurrence or died within 6 months of activity assessment.
Conclusion: Beyond surgical resection and postoperative adjuvant chemotherapy for stage III colon cancer, for patients who survive and are recurrence free approximately 6 months after adjuvant chemotherapy, physical activity appears to reduce the risk of cancer recurrence and mortality.
Comment in
- Cancer survival: time to get moving? Data accumulate suggesting a link between physical activity and cancer survival.
Demark-Wahnefried W. Demark-Wahnefried W. J Clin Oncol. 2006 Aug 1;24(22):3517-8. doi: 10.1200/JCO.2006.06.6548. Epub 2006 Jul 5. J Clin Oncol. 2006. PMID: 16822842 Free PMC article. No abstract available.
Similar articles
- Physical activity and survival after colorectal cancer diagnosis.
Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS. Meyerhardt JA, et al. J Clin Oncol. 2006 Aug 1;24(22):3527-34. doi: 10.1200/JCO.2006.06.0855. Epub 2006 Jul 5. J Clin Oncol. 2006. PMID: 16822844 - Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O'Connell MJ, Wolmark N. Dignam JJ, et al. J Natl Cancer Inst. 2006 Nov 15;98(22):1647-54. doi: 10.1093/jnci/djj442. J Natl Cancer Inst. 2006. PMID: 17105987 - A critical appraisal of treatment for T3N0 colon cancer.
Yo IS, Opelka FG, Bolton JS, Fuhrman GM. Yo IS, et al. Am Surg. 2001 Feb;67(2):143-8. Am Surg. 2001. PMID: 11243538 - [Adjuvant chemotherapy for colon cancer].
Dahl O. Dahl O. Tidsskr Nor Laegeforen. 2007 Nov 29;127(23):3094-6. Tidsskr Nor Laegeforen. 2007. PMID: 18049502 Review. Norwegian. - American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M, Haller DG. Benson AB 3rd, et al. J Clin Oncol. 2004 Aug 15;22(16):3408-19. doi: 10.1200/JCO.2004.05.063. Epub 2004 Jun 15. J Clin Oncol. 2004. PMID: 15199089 Review.
Cited by
- Artificial Intelligence Application for Anti-tumor Drug Synergy Prediction.
Peng Z, Ding Y, Zhang P, Lv X, Li Z, Zhou X, Huang S. Peng Z, et al. Curr Med Chem. 2024;31(40):6572-6585. doi: 10.2174/0109298673290777240301071513. Curr Med Chem. 2024. PMID: 39420717 Review. - Barriers and Facilitators Related to Undertaking Physical Activities in Colorectal Cancer Patients: A Scoping Review.
Yan H, Shuying C, Yuege L, Han K. Yan H, et al. Oncol Rev. 2024 Sep 6;18:1360480. doi: 10.3389/or.2024.1360480. eCollection 2024. Oncol Rev. 2024. PMID: 39309606 Free PMC article. - Walking one hour per day and the derived neutrophil-to-lymphocyte ratio are associated with outcome in palliative second-line immunotherapy for patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.
Caballero-Borrego M, Piedra A, Gallego Ó, López-Pousa A, Castillo P, Navarrete P, Prat A, Grau JJ. Caballero-Borrego M, et al. Braz J Otorhinolaryngol. 2024 Aug 10;90(6):101493. doi: 10.1016/j.bjorl.2024.101493. Online ahead of print. Braz J Otorhinolaryngol. 2024. PMID: 39205362 Free PMC article. - Relevance of Cardiovascular Exercise in Cancer and Cancer Therapy-Related Cardiac Dysfunction.
Wernhart S, Rassaf T. Wernhart S, et al. Curr Heart Fail Rep. 2024 Jun;21(3):238-251. doi: 10.1007/s11897-024-00662-0. Epub 2024 May 2. Curr Heart Fail Rep. 2024. PMID: 38696059 Free PMC article. Review. - Lifestyle Factors and Cancer: A Narrative Review.
Sharman R, Harris Z, Ernst B, Mussallem D, Larsen A, Gowin K. Sharman R, et al. Mayo Clin Proc Innov Qual Outcomes. 2024 Mar 4;8(2):166-183. doi: 10.1016/j.mayocpiqo.2024.01.004. eCollection 2024 Apr. Mayo Clin Proc Innov Qual Outcomes. 2024. PMID: 38468817 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous